User profiles for Łukasz Charzewski

Łukasz Charzewski

Uniwersytet Warszawski
Verified email at fuw.edu.pl
Cited by 121

[HTML][HTML] Structural characterisation of inhibitory and non-inhibitory MMP-9–TIMP-1 complexes and implications for regulatory mechanisms of MMP-9

Ł Charzewski, KA Krzyśko, B Lesyng - Scientific Reports, 2021 - nature.com
MMP-9 plays a number of important physiological functions but is also responsible for many
pathological processes, including cancer invasion, metastasis, and angiogenesis. It is, …

Antimicrobial and KPC/AmpC inhibitory activity of functionalized benzosiloxaboroles

K Durka, AE Laudy, Ł Charzewski, M Urban… - European Journal of …, 2019 - Elsevier
A series of 22 benzosiloxaboroles, silicon analogues of strong antimicrobial agents -
benzoxaboroles, have been synthesized and tested against β-lactamases KPC- and pAmpC-…

Chronic fluoxetine treatment impairs motivation and reward learning by affecting neuronal plasticity in the central amygdala

…, M Winiarski, S Łęski, Ł Charzewski… - British journal of …, 2021 - Wiley Online Library
Background and Purpose The therapeutic effects of fluoxetine are believed to be due to
increasing neuronal plasticity and reversing some learning deficits. Nevertheless, a growing …

[HTML][HTML] Exploring covalent docking mechanisms of boron-based inhibitors to class A, C and D β-lactamases using time-dependent hybrid QM/MM simulations

Ł Charzewski, KA Krzyśko, B Lesyng - Frontiers in Molecular …, 2021 - frontiersin.org
Recently, molecular covalent docking has been extensively developed to design new classes
of inhibitors that form chemical bonds with their biological targets. This strategy for the …

[HTML][HTML] The effect of a novel c. 820C> T (Arg274Trp) mutation in the mitofusin 2 gene on fibroblast metabolism and clinical manifestation in a patient

M Beręsewicz, A Boratyńska-Jasińska, Ł Charzewski… - PLoS …, 2017 - journals.plos.org
Charcot-Marie-Tooth disease type 2A (CMT2A) is an autosomal dominant axonal peripheral
neuropathy caused by mutations in the mitofusin 2 gene (MFN2). Mitofusin 2 is a GTPase …

Evaluation of crowdsourced mortality prediction models as a framework for assessing artificial intelligence in medicine

…, J Prosser, J Gao, G Chen, Ł Charzewski… - Journal of the …, 2024 - academic.oup.com
Objective Applications of machine learning in healthcare are of high interest and have the
potential to improve patient care. Yet, the real-world accuracy of these models in clinical …

[HTML][HTML] Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity

M Beręsewicz, Ł Charzewski, KA Krzyśko… - Scientific Reports, 2018 - nature.com
Charcot-Marie-Tooth disease type 2A (CMT2A) is an autosomal dominant neuropathy caused
by mutations in the mitofusin 2 gene (MFN2). More than 100 MFN2 gene mutations have …

Evaluation of crowdsourced mortality prediction models as a framework for assessing AI in medicine

…, Y Yan, T Yu, J Prosser, J Gao, G Chen, Ł Charzewski… - medRxiv, 2021 - medrxiv.org
Applications of machine learning in healthcare are of high interest and have the potential to
significantly improve patient care. Yet, the real-world accuracy and performance of these …

[HTML][HTML] A molecular dynamics study of vasoactive intestinal peptide receptor 1 and the basis of its therapeutic antagonism

…, I Langer, KA Krzysko, L Charzewski - International Journal of …, 2019 - mdpi.com
Vasoactive intestinal peptide receptor 1 (VPAC1) is a member of a secretin-like subfamily of
G protein-coupled receptors. Its endogenous neuropeptide (VIP), secreted by neurons and …

Alterations in 5hmC level and genomic distribution in aging-related epigenetic drift in human adipose stem cells

…, Z Wicik, J Połosak, O Buyanovskaya, L Charzewski… - …, 2020 - Taylor & Francis
Aim: To clarify mechanisms affecting the level and distribution of 5-hydroxymethylcytosine (5hmC)
during aging. Materials & methods: We examined levels and genomic distribution of …